| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |